SUBSCRIBE
SUBSCRIBE

Abbott Laboratories’ Kaletra HIV-Drug Patent Rejected in India, Allowing Cipla Ltd. Copies

January 4, 2011 | 
1 min read
Bloomberg -- Abbott Laboratories was refused copyright protection on its AIDS drug Kaletra by India’s patent office, allowing Cipla Ltd. and other generic-drug companies to continue selling copies.
Asia
Abbott Laboratories
MORE ON THIS TOPIC
Model of the lungs with the diseased part. Cancer or Ground glass opacity GGO.
Lung cancer
Summit, BioNTech, more headline WCLC with next-gen lung cancer drugs
September 14, 2026
 · 
4 min read
 · 
Gabrielle Masson
3D rendering of a world map with area outlines. 3D illustration of a world map with country outlines.
China
Beyond China: Five other overseas destinations for biopharma dollars
September 9, 2026
 · 
8 min read
 · 
Tristan Manalac
Creative design. Desperate employee, office worker standing near question mark symbolizing business struggles, options. Choosing strategy for achieving goal. Concept of business, career development
Business
4 CDMOs to consider when outsourcing manufacturing
September 8, 2026
 · 
5 min read
 · 
Angela Gabriel
Rocket takeoff, gold light bulb on light blue background. Concept of start up launch and creativity. 3D rendering
Startups
10 life sciences startups selected for accelerator program
September 4, 2026
 · 
2 min read
 · 
Angela Gabriel